Cencora, Inc.

CORNYSEHealthcare● Active

$275.04

+$4.72(+1.75%)

Market Cap$53.5B

P/E Ratio—

52W High$377.54

52W Low$244.82

Avg Volume1.8M

Open$272.61

Beta0.59

Overview

Cencora, Inc. (COR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

COR · free cash flow · updated Jun 8, 2026

Core FCF metrics

COR · FCF · TTM · margin & CAGR

Free cash flow was $3.21B for FY2025 (fiscal year ending 2025-09-30), up 7.0% year-over-year The FCF margin was 1.0%. Five-year CAGR stands at +11.8%.

FY2025 Free Cash Flow$3.21B▲ +7.0% YoY

Trailing 12M (TTM)$1.56Btrailing 4 quarters sum

FCF Margin1.0%$3.21B ÷ revenue

3-Year CAGR+13.3%FY2022 → FY2025

5-Year CAGR+11.8%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

COR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$3.88B(668M)$3.21B▲ +7.0%1.0%

FY2024$3.48B(487M)$3.00B▼ 13.2%1.0%

FY2023$3.91B(458M)$3.45B▲ +56.5%1.3%

FY2022$2.70B(496M)$2.21B▼ 1.0%0.9%

FY2021$2.67B(438M)$2.23B▲ +21.3%1.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

COR · P/FCF · FCF yield · FCF per share

Cencora, Inc. (COR) trades at a FCF yield of 2.91% and a price-to-free-cash-flow ratio of 34.2x. FCF per share stands at $8.04, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

2.91%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$8.04

TTM FCF ÷ Shares Outstanding

Price / FCF

x34.2

Share Price ÷ FCF per Share

EV / FCF (TTM)

x40.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-09-30

Cash flow statement summary

COR · cash flow statement · operating / investing / financing

For FY2025, Cencora, Inc. generated $3.88B in operating cash flow and spent 668M in capital expenditures, yielding $3.21B in free cash flow.

Operating Activities

+$3.88B

Cash from core business operations

2025-09-30

Investing Activities

−$4.98B

CapEx, acquisitions & investments

2025-09-30

Financing Activities

+$2.25B

Buybacks, dividends & debt

2025-09-30

FCF FormulaOperating CF ($3.88B) − |CapEx| (668M) = FCF ($3.21B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

COR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Cencora, Inc.YOU

COR

$3.21B+7.0%1.0%

16%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cencora, Inc. (COR) reported free cash flow of $3.21B for FY2025 (fiscal year ending 2025-09-30), up 7.0% year-over-year. The FCF margin was 1.0%.

Based on available data, Cencora, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $3.69B in FY2015. The 5-year CAGR stands at +11.8%.

Cencora, Inc.'s FCF yield is 2.91% and price-to-FCF ratio is 34.2x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

COR free cash flow · 8 questions

Cencora, Inc. free cash flow was $3.21B for FY2025, up 7.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.56B.

COR free cash flowCOR FCFCOR FCF 2025COR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Cencora, Inc. · Cencora, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026